1 / 20

Killing Bacteria Ain’t Easy

Killing Bacteria Ain’t Easy. Definitions. Sterilization Destruction or removal of all viable organisms (including more resilient forms – bacterial spores, mycobacteria, naked viruses, fungi) Only on inanimate objects Disinfection Killing, inhibition, or removal of pathogenic organisms

saniya
Download Presentation

Killing Bacteria Ain’t Easy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Killing Bacteria Ain’t Easy

  2. Definitions • Sterilization • Destruction or removal of all viable organisms (including more resilient forms – bacterial spores, mycobacteria, naked viruses, fungi) • Only on inanimate objects • Disinfection • Killing, inhibition, or removal of pathogenic organisms • Disinfectants = Agents, usually chemical, used for disinfection (usually used on inanimate objects) • Sanitization • Reduction of microbial population to levels deemed safe (based on public health standards)

  3. Antisepsis • Prevention of infection of living tissue by microorganisms • Antiseptics • Chemical agents that kill or inhibit growth of microorganisms when applied to living tissue • -cidal suffix indicates agents that kill • Germicide • Kills pathogens and many nonpathogens but not necessarily endospores • Include bactericides, fungicides, algicides,viricides

  4. Physical Methods in Control • Heat (dry heat; moist heat) • Filtration • Radiation (ultraviolet radiation; ionizing radiation) • Generally used to sterilize objects and control microbial growth

  5. Pasteurization • Process of heating food or other substance under controlled conditions of time and temperature to kill pathogens and reduce total number of microbes without damaging the substance (i.e. altering taste) • Controlled heating using high temperature short time = temperatures well below boiling (72°C for not less than 16 seconds) + rapid cooling • Used for milk, beer and other beverages • Process does not sterilize but does kill pathogens present and slow spoilage by reducing the total load of organisms present (→ 5 log reduction in viable microbes)

  6. Chemical Control Agents • Most act by causing chemical damage to proteins, nucleic acids or cell membrane lipids

  7. Cidal vs. Static effect • Bactericidal → kills bacteria • Bacteriostatic → only inhibits growth (growth resumes if antibiotic removed) • Spectrum of Activity • Narrow spectrum → active against few species only • Broad spectrum → active against many different species

  8. Mechanisms of Action of Antibiotics • Four Main Target Sites for Antibacterial Action • Cell wall synthesis • Protein synthesis • Nucleic acid synthesis • Cell membrane function

  9. Inhibitors of Cell Wall Synthesis • Peptidoglycan is: • Vital component of bacterial cell wall • Unique to bacteria (good for selective toxicity) • Beta-lactams: • Penicillin derivatives, cephalosporins • Inhibit cell wall synthesis by binding to penicillin-binding proteins (PBPs) • PBPs are membrane proteins capable of binding to penicillin that are responsible for final stages of cross-linking of bacterial cell wall structure → Osmotic lysis of bacterial due to incomplete peptidoglycan layer • Non-beta-lactams: • Vancomycin • act at various steps during peptidoglycan synthesis • NOTE: Only cells which are metabolically active and dividing are affected

  10. Inhibitors of Protein Synthesis • Aminoglycosides • Tetracyclines • Macrolides • Chloramphenicol

  11. Inhibitors of Nucleic Acid Synthesis • Quinolones • Inactivate DNA gyrase → no chromosome supercoiling → no DNA replication • Eukaryotic gyrase is ≈ 1000 X less sensitive to quinolones • Rifampin • Binds to RNA polymerase → prevents transcription of DNA into RNA, so no proteins are made.

  12. Side Effects of Antibiotic Use • Toxicity to host • After high-dose, long-term use (ex. tetracycline → discolored teeth) • Allergic reactions • Penicillin: 1 - 3% of population is allergic • Disruption of “normal flora” • Broad spectrum antibiotics may alter “balance” of bacteria in gut →“Superinfection” • Organisms not killed by antibiotic will grow & predominate → increase in #’s of one species due to absence of competition • Ex. “Antibiotic-associated colitis” due to overgrowth of Clostridium difficile

  13. Methicillin-resistant Staphylococcus aureus(MRSA) • SA → pneumonia, skin & soft tissue infections, bloodstream • Treatment of choice is methicillin or derivatives (eg. Cloxacillin) -- cost ≈ $30.00 for standard 10-day course • MRSA → resistant to methicillin (+ related antibiotics) • 1st seen in Canada in 1981 • 1995: 0.9 MRSA per 100 SA isolates • 2001: 8.2 MRSA per 100 SA isolates • Treatment options are limited • Vancomycin - $200.00 for 10-day intravenous course • Total cost to treat 1 hospitalized isolated MRSA patient ≈ $14,000 • Total cost associated with MRSA in Canada: $42-59 million/yr

  14. New Sources of Antibiotics • Continue screening of new bacteria & fungi from environment • Do undiscovered antibiotics still exist?? • Rejuvenate existing antibiotics • Chemical modifications to resist bacterial inactivation • Novel non-microbial sources of antibiotics • Plants → anti-bacterial, anti-tumor drugs • Vertebrates, invertebrates, insects → antimicrobial peptides • Rational drug design • pick specific bacterial target & deduce structure / function • synthesize a chemical which acts against target

  15. Direct inactivation of antibiotic • Bacteria produce enzymes which break-down antibiotic • eg. β - lactamase (penicillinase) enzymes → hydrolyze β - lactam ring of penicillins

  16. Alteration of antibiotic target • Mutated target no longer recognized by antibiotic • Ex. Aminoglycoside resistance → aminoglycoside-modifying enzymes inactivate the antibiotics

  17. Prevent uptake or promote excretion of antibiotic • Active efflux through efflux pumps: ABC transporters • Ex. Tetracycline resistance -- rapid excretion via outer membrane “efflux” proteins → no accumulation of drug in cytoplasm • Reduced uptake across the cytoplasmic membrane • Ex. Cephalosporin resistance -- altered protein in membrane prevents entry

  18. How do bacteria acquire resistance? • Spontaneous mutation in DNA (eg. to give altered drug target) • Low frequency events, but presence of drug in environment exerts selective pressure so that mutant cells persist • Horizontal Gene Transfer: Obtain new resistance genes (eg. gene for β - lactamase) • Often plasmid-mediated • Genetic exchange from donor bacteria with resistance plasmid • Multiple resistance may be obtained in a single genetic event (eg. one plasmid carrying several resistance genes)

  19. A chromosomal mutation (a) can produce a drug resistant target, which confers resistance on the bacterial cell and allows it to multiply in the presence of antibiotic. • Resistance genes carried on plasmids (b) can spread from one cell to another more rapidly than cells themselves divide and spread. • Resistance genes on transposable elements (c) move between plasmids and the chromosome and from one plasmid to another, thereby allowing greater stability or greater dissemination of the resistance gene.

More Related